Free Trial

Anpario (LON:ANP) Sets New 12-Month High - Here's What Happened

Anpario logo with Consumer Defensive background

Key Points

  • Anpario plc shares reached a new 52-week high of GBX 518.99 during trading, closing at GBX 505 with a total volume of 60,856 shares.
  • Shore Capital has reaffirmed its "house stock" rating for Anpario, and the company currently holds an average Buy rating with a price target of GBX 500.
  • Anpario reported earnings of GBX 16.87 per share for the last quarter, with analysts predicting an annual earnings per share of approximately 23.58 for the current fiscal year.
  • MarketBeat previews top five stocks to own in October.

Anpario plc (LON:ANP - Get Free Report) shares hit a new 52-week high during trading on Thursday . The company traded as high as GBX 518.99 ($6.93) and last traded at GBX 505 ($6.74), with a volume of 60856 shares trading hands. The stock had previously closed at GBX 495 ($6.61).

Wall Street Analysts Forecast Growth

Separately, Shore Capital reaffirmed a "house stock" rating on shares of Anpario in a research report on Tuesday. One analyst has rated the stock with a Buy rating, According to MarketBeat, Anpario currently has an average rating of "Buy" and an average price target of GBX 500.

Read Our Latest Research Report on ANP

Anpario Trading Up 2.0%

The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. The firm has a market cap of £85.58 million, a price-to-earnings ratio of 2,067.98 and a beta of 0.58. The business's fifty day moving average is GBX 420.01 and its two-hundred day moving average is GBX 415.82.

Anpario (LON:ANP - Get Free Report) last issued its quarterly earnings results on Wednesday, September 10th. The company reported GBX 16.87 earnings per share for the quarter. Anpario had a net margin of 9.23% and a return on equity of 8.74%. Equities analysts anticipate that Anpario plc will post 23.5757801 earnings per share for the current fiscal year.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.